Immunovant, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
IMVT Nasdaq 2836 immunovant.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Immunovant, Inc.

Immunovant's Risk/Reward Profile Balanced After Recent Rally, UBS Says - Aug 24th, 2026 11:16 am
Immunovant (IMVT) Q1 2027 Earnings Call Transcript - Aug 13th, 2026 6:01 am
Roivant Sciences Q1 Earnings Call Highlights - Aug 7th, 2026 5:03 am
Immunovant, Inc. Q1 2027 Earnings Call Summary - Aug 6th, 2026 3:51 pm
Immunovant Q1 Earnings Call Highlights - Aug 6th, 2026 1:04 pm
Immunovant's Q1 Loss Wider Than Expected, Pipeline in Progress - Aug 6th, 2026 9:22 am
Immunovant Provides Corporate Updates and Reports Financial Results for the Quarter Ended June 30, 2026 - Aug 6th, 2026 5:00 am
Immunovant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026 - Jul 23rd, 2026 2:05 pm
Immunovant (IMVT) Up 3.6% Since Last Earnings Report: Can It Continue? - Jun 19th, 2026 9:30 am
Chronic Inflammatory Demyelinating Polyneuropathy Market Gains Traction During the Forecast Period (2026-2036) with Advancing Clinical Research Activities | DelveInsight - Jun 18th, 2026 8:01 am
Immunovant Stock Gains 12.4% in a Month: What's Driving It? - Jun 12th, 2026 8:08 am
Assessing Immunovant (IMVT) Valuation After Strong IMVT 1402 Phase 2 Rheumatoid Arthritis Trial Commentary - Jun 5th, 2026 2:12 am
H.C. Wainwright Raises Price Target on Immunovant (IMVT) Following Positive Rheumatoid Arthritis Trial Data - Jun 2nd, 2026 3:38 am
Truist Lifts PT on Immunovant, Inc. (IMVT) But Maintains a Hold Rating - May 28th, 2026 5:01 am
This Biotech Is Up 60%. A Top Healthcare Fund Just Bought Another $11 Million - May 24th, 2026 8:39 am
This Biotech Stock Is Up 355%. One Fund Added a $169 Million Position Last Quarter - May 24th, 2026 8:33 am
What to Know About This Fund's $6.6 Million UroGen Sale After a 600% Stock Surge - May 23rd, 2026 4:40 pm
Why a Biotech Fund Opened a New $6 Million Position in Vir Amid a 99% Stock Rally - May 23rd, 2026 4:33 pm